Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 4 boards, counting each seat separately. Longest: Zura Bio Limited, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Zura Bio Limited June 17, 202671.5%
-
Inhibikase Therapeutics Inc. June 27, 202598.4%
-
Zura Bio Limited May 21, 202599.1%
-
Zura Bio Limited October 23, 2024100.0%
-
Damora Therapeutics Inc. June 14, 202399.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Arcutis Biotherapeutics Inc. | Grant or award | +5,778 | — | — |
| Feb 21, 2026 | Inhibikase Therapeutics Inc. | Sold back to the company | −19,089 | — | — |
| Dec 4, 2025 | Arcutis Biotherapeutics Inc. | Grant or award | +2,021 | — | — |
| Feb 21, 2025 | Inhibikase Therapeutics Inc. | Grant or award | +57,265 | — | — |
| Oct 21, 2024 | Inhibikase Therapeutics Inc. | Open-market purchase | +365,000 | $1.37 | $500,050 |
| Apr 22, 2024 | Zura Bio Limited | Open-market purchase | +159,744 | $3.13 | $499,999 |
| Jun 5, 2023 | Zura Bio Limited | Open-market purchase | +117,647 | $4.25 | $500,000 |
Questions about Amit Munshi
What boards is Amit Munshi on?
Amit Munshi sits on the boards of Arcutis Biotherapeutics Inc., Damora Therapeutics Inc., Inhibikase Therapeutics Inc. and Zura Bio Limited.
How long has Amit Munshi served on boards?
Our records show at least 10 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.